PubRank

T A Fleisher

Author PubWeight™ 104.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995 6.77
2 Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med 1990 2.82
3 A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells. J Immunol 1981 2.73
4 Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods 1995 2.35
5 The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 2001 2.15
6 Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 1993 2.14
7 A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest 1992 2.13
8 Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 1997 2.10
9 Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N Engl J Med 1994 2.07
10 Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features. Blood 1990 2.02
11 Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac. Blood 1995 1.99
12 Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 1994 1.79
13 Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am J Hum Genet 1999 1.74
14 Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 1997 1.73
15 Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol 1998 1.59
16 Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 1997 1.58
17 Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood 2001 1.55
18 Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proc Natl Acad Sci U S A 1997 1.48
19 Comparative analysis of whole blood lysis methods for flow cytometry. Cytometry 1997 1.47
20 The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort. Transfusion 2010 1.45
21 A pilot study of 2-chloro-2'-deoxyadenosine in the treatment of systemic lupus erythematosus-associated glomerulonephritis. Arthritis Rheum 1998 1.43
22 Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood 2001 1.42
23 Pathological findings in human autoimmune lymphoproliferative syndrome. Am J Pathol 1998 1.41
24 Increased peripheral T lymphocyte activation in patients with karyotypically normal spontaneous premature ovarian failure. Fertil Steril 1991 1.39
25 Comparison of two automated nephelometers. J Clin Lab Anal 1992 1.39
26 Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-gamma receptor 1 deficiency. J Infect Dis 1998 1.35
27 Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. I. Characterization of a soluble suppressor T cell proliferation. J Immunol 1981 1.34
28 TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis. Clin Immunol 2001 1.20
29 Frequency analysis of IgE-secreting B lymphocytes in persons with normal or elevated serum IgE levels. J Immunol 1991 1.19
30 IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis. J Immunol 2001 1.11
31 Detection of intracellular phosphorylated STAT-4 by flow cytometry. Clin Immunol 2001 1.10
32 T and B lymphocyte subpopulations in children. Pediatrics 1975 1.09
33 Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac. Ann Neurol 1998 1.08
34 Measurement of T-cell CD69 expression: a rapid and efficient means to assess mitogen- or antigen-induced proliferative capacity in normals. Cytometry 1996 1.08
35 IgG and IgM anticardiolipin antibodies in patients with lupus with anticardiolipin antibody associated clinical syndromes. J Rheumatol 1988 1.08
36 Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease. J Pediatr 1996 1.07
37 X-linked hypogammaglobulinemia and isolated growth hormone deficiency. N Engl J Med 1980 1.07
38 Unexpected and variable phenotypes in a family with JAK3 deficiency. Genes Immun 2001 1.05
39 Safety and efficacy of strength training in patients with sporadic inclusion body myositis. Muscle Nerve 1997 1.04
40 Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival. Pediatr Clin North Am 2000 1.03
41 Granulocyte colony-stimulating factor recruitment of CD34+ progenitors to peripheral blood: impaired mobilization in chronic granulomatous disease and adenosine deaminase--deficient severe combined immunodeficiency disease patients. Blood 1996 1.03
42 The interference of T cell activation by calcium channel blocking agents. J Immunol 1984 1.01
43 Intestinal lymphangiectasia, a disease characterized by selective loss of naive CD45RA+ lymphocytes into the gastrointestinal tract. Eur J Immunol 1998 1.00
44 Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults. Blood 2000 0.98
45 Immunoglobulin G antineutrophil cytoplasmic antibodies are produced in the respiratory tract of patients with Wegener's granulomatosis. Am Rev Respir Dis 1991 0.98
46 Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. II. Characterization of a soluble suppressor of B cell immunoglobulin production. J Immunol 1981 0.97
47 The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphoma. Leuk Lymphoma 2001 0.96
48 Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection. Am J Pathol 2000 0.96
49 Normalization of antibody responsiveness in a patient with common variable hypogammaglobulinemia and HIV infection. N Engl J Med 1987 0.96
50 Limited prognostic value of changes in antineutrophil cytoplasmic antibody titers in patients with Wegener's granulomatosis. Adv Exp Med Biol 1993 0.92
51 Management of neutralizing antibody to Ceredase in a patient with type 3 Gaucher disease. Pediatrics 1997 0.91
52 Bronchoalveolar lavage analysis in Wegener's granulomatosis. A method to study disease pathogenesis. Am Rev Respir Dis 1991 0.90
53 Frequent occurrence of asplenism and cholelithiasis in patients with autoimmune polyglandular disease type I. Am J Med 1991 0.88
54 Production of human suppressor T cell hybridomas. J Immunol 1982 0.88
55 Corticosteroid-responsive intestinal lymphangiectasia secondary to an inflammatory process. N Engl J Med 1979 0.88
56 Characterization of a soluble suppressor of human B cell immunoglobulin biosynthesis produced by a continuous human suppressor T cell line. J Exp Med 1981 0.87
57 Characterization of a new IL-6-dependent human B-lymphoma cell line in long term culture. Cytokine 1993 0.87
58 The role of Fas and related death receptors in autoimmune and other disease states. J Allergy Clin Immunol 1999 0.86
59 Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum. J Clin Invest 1993 0.86
60 Practice parameters for the diagnosis and management of immunodeficiency. The Clinical and Laboratory Immunology Committee of the American Academy of Allergy, Asthma, and Immunology (CLIC-AAAAI) Ann Allergy Asthma Immunol 1996 0.86
61 Effect of chronic treatment with the glucocorticoid antagonist RU 486 in man: toxicity, immunological, and hormonal aspects. J Clin Endocrinol Metab 1990 0.85
62 Interferon-mediated inhibition of human polyclonal immunoglobulin synthesis. J Immunol 1982 0.84
63 Human T cell activation induces the expression of a novel CD45 isoform that is analogous to murine B220 and is associated with altered O-glycan synthesis and onset of apoptosis. Cell Immunol 2001 0.84
64 A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy. Clin Nephrol 1999 0.83
65 Efficient detection of thirty-seven new IL2RG mutations in human X-linked severe combined immunodeficiency. Clin Immunol 2000 0.83
66 Native C3 does not bind to the C3b receptor (CR1) of human blood B lymphocytes or alter immunoglobulin synthesis. J Immunol 1983 0.81
67 Characterization of a soluble suppressor of human B cell function produced by a continuous human suppressor T cell line. II. Evidence for suppression through a direct action of CTC-SISS-B on human B cells. J Immunol 1982 0.80
68 A pilot study of anti-CD5 ricin A chain immunoconjugate in systemic lupus erythematosus. J Rheumatol 1994 0.80
69 Lymphocyte depletion with fludarabine in patients with psoriatic arthritis: clinical and immunological effects. Ann Rheum Dis 2003 0.80
70 Correction of ADA deficiency in human T lymphocytes using retroviral-mediated gene transfer. Transplant Proc 1991 0.80
71 Immunological activities of recombinant interferon-alpha 2 and its A fragment. J Interferon Res 1987 0.80
72 A solid phase enzyme immunoassay (ELISA) for the detection and quantitation of anticardiolipin antibody. Am J Clin Pathol 1988 0.79
73 Parasitic modulation of host immune mechanisms in schistosomiasis. Int Arch Allergy Appl Immunol 1987 0.79
74 Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma. Clin Cancer Res 1998 0.78
75 Cellular immunity to cytomegalovirus in a patient following bone marrow transplantation. Transplantation 1978 0.78
76 Application of lymphocyte immunophenotyping in selected diseases. Pathol Immunopathol Res 1988 0.78
77 Autocrine activation of hemopoietic progenitor-derived myelo-monocytic cells by IFN-gamma gene transfer. J Immunol 1996 0.78
78 Introduction to flow cytometry. Semin Hematol 2001 0.77
79 Immunophenotyping. Semin Hematol 2001 0.77
80 Serum antibody detected by fluorescent antibody test in patients with symptomatic Blastocystis hominis infection. Recenti Prog Med 1995 0.77
81 High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis. J Rheumatol 1998 0.76
82 Isotype determination of antibodies. Curr Protoc Immunol 2001 0.76
83 Testing for chronic granulomatous disease. Lancet 1996 0.75
84 Suppression of human T and B lymphocyte activation by Agaricus bisporus lectin. I. Suggestive evidence for a surface "suppressor" receptor in human lymphocytes. J Immunol 1981 0.75
85 Immunoregulatory effects of C3 and its major cleavage fragments. Clin Immunol Immunopathol 1984 0.75
86 In vitro effect of alpha-interferon on mononuclear cells of normal and autoimmune patients. Int Arch Allergy Appl Immunol 1987 0.75
87 Immunologic mechanisms in the prevention and therapy of cancer. Am J Dis Child 1974 0.75
88 Reduced granulocyte-macrophage colony-stimulating activity by mitogen-stimulated lymphocytes from patients with aplastic anaemia. Br J Haematol 1979 0.75
89 Construction of human suppressor T cell hybridomas. Lymphokine Res 1983 0.75
90 Introduction to diagnostic laboratory immunology. JAMA 1997 0.75
91 Cell function-based flow cytometry. Semin Hematol 2001 0.75
92 Magnesium content and concentration of mononuclear and T lymphocyte blood cells. Magnesium 1988 0.75
93 Lymphocyte analysis in a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency after development of echovirus dermatomyositis and meningoencephalitis. Int Arch Allergy Appl Immunol 1989 0.75
94 Isotype determination of antibodies. Curr Protoc Mol Biol 2001 0.75
95 Letter: Leukocyte function in aspartylglucosaminuria. J Pediatr 1975 0.75
96 Stimulation of immunoglobulin biosynthesis in human B cells by wheat germ agglutinin. I. Evidence that WGA can produce both a positive and negative signal for activation of human lymphocytes. J Immunol 1981 0.75
97 The role of cell surface lectin--carbohydrate interactions in cellular recognition, cooperation, and regulation. Am J Pediatr Hematol Oncol 1983 0.75
98 Inter-laboratory survey of lymphocyte immunophenotyping. Pathol Immunopathol Res 1988 0.75
99 Bone marrow transplantation in congenital hypoplastic anemia. Blood 1977 0.75